News – Page 494 – Endpoints News

Lynparza fails a PhIII test in colorectal cancer, cutting off big R&D avenue for Merck and AstraZeneca

3 years ago

Safety scare cleared and early data in hand, Ultragenyx dishes out $75M to buy rare disease partner

3 years ago

Following Luxturna and slate of eye disease approvals, Roche adds another ophthalmology partner for AAV gene ...

3 years ago

Eisai shutters oncology unit, cuts around 80 jobs

3 years ago

Biogen sees more than 330 departures from MA-based sites since last summer

3 years ago

GSK nets a deal with Canadian government for flu vaccine manufacturing

3 years ago

Khloé Kardashian strikes again with migraine med Nurtec marketing in ‘all in one’ push

3 years ago

MilliporeSigma uses DOD funds to expand Wisconsin-based manufacturing site

3 years ago

Pharma R&D spending in the US more than doubles in a decade, PhRMA survey finds

3 years ago

Europe buys 54,000 more doses of Bavarian Nordic's monkeypox vaccine as cases increase

3 years ago

Amgen expands StoryCorps oncology campaign with celebrity actor, preps for upcoming health equity stories

3 years ago

GSK's consumer health unit Haleon off to a rough start

3 years ago

BlackRock joins Andrew Lo's risk analysis firm to search for odds-on biotech bets in turbulent times

3 years ago

Editas hires top Sanofi scientist for CMO as C-suite shuffle continues

3 years ago

Immunocore is the latest to nab a private placement, securing $140M to pursue more TCR R&D

3 years ago

An old epilepsy med gets oral liquid formulation nod; PMV pairs up ASCO standout with Keytruda

3 years ago

Weeks after rare disease drug got spurned, Acer returns to FDA for second shot

3 years ago

Sesen Bio pauses bladder cancer drug work, offloads eye disease antibodies to Roche

3 years ago

Eliem delays a depression trial, indefinitely postpones another after blaming CMC issues for low drug exposure

3 years ago

Sanofi waves the white flag on Regulus' microRNA program targeting rare kidney disease

3 years ago

Samsung’s CDMO arm commits to $324M land purchase for a second bio campus

3 years ago

Oxford Science Enterprises collects $300M to offer spinouts 'scale-up capital'

3 years ago

DNA sequencing giant Illumina battles antitrust regulators and growing competition

3 years ago

Nestlé puts down $40M, kicks off deal with gut microbiome specialist to fight food allergies

3 years ago

First page Previous page 491 492 493494495 496 497 Next page Last page